Literature DB >> 12230323

Human secreted attractin disrupts neurite formation in differentiating cortical neural cells in vitro.

Wen Tang1, Jonathan S Duke-Cohan.   

Abstract

Mutations at the Atrn locus that encodes a transmembrane protein with a large ectodomain are responsible for a juvenile-onset neurodegeneration manifest as hypomyelination and cerebral vacuole development in several rodent species. In addition to a membrane isoform, the human Atm locus generates by alternative splicing a secreted form corresponding to the entire ectodomain that then circulates at high concentration in the periphery, released in part by activated T lymphocytes. We report here that the secreted form mRNA is downregulated throughout representative discrete regions of the human brain while membrane attractin mRNA is well represented, resulting in the apparent absence of secreted attractin protein in cerebrospinal fluid (CSF). Transcription of attractin secreted form mRNA is strongly downregulated upon differentiation of a human cortical neuron-derived cell line (HCN-1A) to a mature neuron phenotype in response to nerve growth factor. Recombinant secreted attractin disrupts neurite formation by differentiated HCN-1A cells, resulting in higher levels of branching with shorter processes. This effect is duplicated by anti-attractin and by human serum but not by human serum depleted of attractin or by CSF We propose that inappropriate expression of secreted attractin in the CNS blocks membrane attractin function and that its presence, either by leakage from the periphery, aberrant transcription, or release from inflammatory foci may affect neuron extracellular interactions leading to neurodegeneration in the human.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230323     DOI: 10.1093/jnen/61.9.767

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

Review 1.  Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.

Authors:  Fang Shen; Yang Zhang; Yu Yao; Wei Hua; Hai-Shi Zhang; Jing-Song Wu; Ping Zhong; Liang-Fu Zhou
Journal:  Neurosurg Rev       Date:  2014-05-01       Impact factor: 3.042

2.  Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients.

Authors:  Fatima W Khwaja; Matthew S Reed; Jeffrey J Olson; Brian J Schmotzer; G Yancey Gillespie; Abhijit Guha; Morris D Groves; Santosh Kesari; Jan Pohl; Erwin G Van Meir
Journal:  J Proteome Res       Date:  2007-02       Impact factor: 4.466

3.  Alkbh4 and Atrn Act Maternally to Regulate Zebrafish Epiboly.

Authors:  Qingrui Sun; Xingfeng Liu; Bo Gong; Di Wu; Anming Meng; Shunji Jia
Journal:  Int J Biol Sci       Date:  2017-09-02       Impact factor: 6.580

4.  Post-developmental extracellular proteoglycan maintenance in attractin-deficient mice.

Authors:  Abdallah Azouz; Jonathan S Duke-Cohan
Journal:  BMC Res Notes       Date:  2020-06-24

5.  Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways.

Authors:  Daniela Rodrigues-Amorim; Tania Rivera-Baltanás; María Del Carmen Vallejo-Curto; Cynthia Rodriguez-Jamardo; Elena de Las Heras; Carolina Barreiro-Villar; María Blanco-Formoso; Patricia Fernández-Palleiro; María Álvarez-Ariza; Marta López; Alejandro García-Caballero; José Manuel Olivares; Carlos Spuch
Journal:  Front Psychiatry       Date:  2019-11-29       Impact factor: 4.157

6.  Proteome profile of patients with excellent and poor speech intelligibility after cochlear implantation: Can perilymph proteins predict performance?

Authors:  Martin Durisin; Caroline Krüger; Andreas Pich; Athanasia Warnecke; Melanie Steffens; Carsten Zeilinger; Thomas Lenarz; Nils Prenzler; Heike Schmitt
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

7.  Non-cell autonomous impairment of oligodendrocyte differentiation precedes CNS degeneration in the Zitter rat: implications of macrophage/microglial activation in the pathogenesis.

Authors:  Shin-ichi Sakakibara; Kazuhiko Nakadate; Shigeo Ookawara; Shuichi Ueda
Journal:  BMC Neurosci       Date:  2008-04-05       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.